Hang Trinh
Family · Lubbock, TXNPI 1336510908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.7% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by Medtronic at 29.8% of the total. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $36.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Relievant Medsystems, Inc.$2K
- AbbVie$1K
- Abbott$943
- Boston Scientific$509
- Si-bone, Inc.$317
- plus $3K from 31 others
What the payments were for
- Travel & lodging$8768%
- Food & beverage$9,63192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 125 | $3,126 |
| Relievant Medsystems, Inc. | 15 | $1,507 |
| AbbVie | 43 | $1,011 |
| Abbott | 10 | $943 |
| Boston Scientific | 13 | $509 |
| Si-bone, Inc. | 3 | $317 |
| Pfizer | 22 | $278 |
| Biohaven Pharmaceuticals, Inc. | 6 | $252 |
| Collegium Pharmaceutical, Inc. | 14 | $225 |
| AstraZeneca | 2 | $190 |
| Globus Medical | 1 | $172 |
| Saluda Medical Americas, Inc. | 2 | $170 |
| Inspire Medical Systems, Inc. | 2 | $159 |
| MML US, Inc. | 1 | $145 |
| Dexcom, Inc. | 1 | $143 |
| Nalu Medical, Inc. | 2 | $135 |
| Spinal Simplicity, LLC | 2 | $128 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Sanofi | 1 | $123 |
| GSK | 1 | $114 |
| Amgen(2 entities) | 2 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $102 |
| Otsuka America Pharmaceutical, Inc. | 1 | $78 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $54 |
| Johnson & Johnson | 1 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Averitas Pharma Inc. | 1 | $35 |
| Vertex | 1 | $20 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Novo Nordisk | 1 | $16 |
| Novartis | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
| Acacia Pharma Inc | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Lundbeck LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$4,688
- INTELLIS ADAPTIVESTIM$786
- PROCLAIM$444
- Senza$172
- ReActiv8$145
- DEXCOM G6 TRANSMITTER$143
- SYNCHROMEDII$143
- FREESTYLE LIBRE 3$141
- Evoke$130
- GENERAL - THERAPIES$124
- VOQUEZNA$123
- FABRAZYME$123
- VRAYLAR$122
- Nalu Neurostimulation System$119
- Inspire$115
- BENLYSTA$114
- OSTEOCOOL RF ABLATION$111
- CAPLYTA$103
- GATTEX$102
- NURTEC ODT$102
How this compares
$10,507 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 152 | $1,858 |
| Methocarbamol | 76 | $896 |
| Tizanidine Hcl | 51 | $695 |
| Baclofen | 35 | $662 |
| Pregabalin | 37 | $617 |
| Tramadol Hcl | 27 | $602 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $568 |
| Duloxetine Hcl | 39 | $548 |
| Tramadol Hcl ErTramadol Hcl | 11 | $475 |
| Cyclobenzaprine Hcl | 54 | $356 |
| Ropinirole Hcl | 27 | $262 |
| Celecoxib | 25 | $259 |
| Nabumetone | 12 | $256 |
| Amitriptyline Hcl | 15 | $125 |
| Ibuprofen | 19 | $107 |
Paid to pharmacies, not to this prescriber.
Other family in Lubbock
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.